Cinctive Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Sell
16,707
-30,999
-65% -$3.58M 0.13% 206
2025
Q4
$5.02M Sell
47,706
-40,776
-46% -$3.83M 0.27% 105
2025
Q3
$7.43M Buy
88,482
+41,456
+88% +$3.41M 0.36% 95
2025
Q2
$3.72M Buy
+47,026
New +$3.74M 0.2% 155
2024
Q3
Sell
-100,815
Closed -$12.5M 461
2024
Q2
$12.5M Buy
100,815
+63,210
+168% +$8.14M 0.59% 38
2024
Q1
$4.96M Buy
37,605
+22,973
+157% +$2.83M 0.23% 129
2023
Q4
$1.6M Buy
+14,632
New +$1.52M 0.11% 202
2021
Q4
Sell
-214,690
Closed -$16.1M 612
2021
Q3
$16.1M Buy
+214,690
New +$16.3M 0.79% 13

Other funds holding MRK

Cinctive Capital Management's MRK Position: Q1 2026 in Review

Cinctive Capital Management reduced its Merck (MRK) stake by 65% in Q1 2026, selling an estimated $3.58M and leaving 16,707 shares worth $2.01M. The position accounts for 0.13% of the portfolio, ranked #206.

Cinctive Capital Management first reported a position in MRK in Q3 2021 and has held it in 8 quarters since. The position peaked at $16.1M in Q3 2021. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cinctive Capital Management held 16,707 shares of Merck worth $2.01M as of Q1 2026.
  • Cinctive Capital Management sold 30,999 Merck shares in Q1 2026, an estimated $3.58M.
  • Merck made up 0.13% of Cinctive Capital Management's portfolio in Q1 2026, its #206 holding.
  • Cinctive Capital Management first reported a position in Merck in Q3 2021 and has held it in 8 quarters since.
  • Cinctive Capital Management's Merck position peaked at $16.1M in Q3 2021.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.